Initiating Research Reports on Electronic Equipment Equities -- Apple, Fabrinet, Koninklijke Philips, and Sony

NEW YORK, October 25, 2017 /PRNewswire/ --

If you want a Stock Review on AAPL, FN, PHG, or SNE then come over to and sign up for your free customized report. This morning, navigates the Electronic Equipment industry, which includes companies that design, manufacture, and sell electrical and electronic products for consumer and industrial use. These products can range from lighting solutions to medical equipment. Electronic equipment makers generally offer below-average dividend yields. Equities under evaluation today are: Apple Inc. (NASDAQ: AAPL), Fabrinet (NYSE: FN), Koninklijke Philips N.V. (NYSE: PHG), and Sony Corp. (NYSE: SNE). This morning's free research reports on the aforesaid equities are available upon registration on at:


Cupertino, California headquartered Apple Inc.'s stock finished Tuesday's session 0.60% higher at $157.10 with a total trading volume of 17.63 million shares. The Company's shares have advanced 4.35% in the past month, 2.37% over the previous three months, and 35.64% on an YTD basis. The stock is trading above its 200-day moving average by 7.26%. Furthermore, shares of Apple, which designs, manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players to consumers, small and mid-sized businesses, and education, enterprise, and government customers worldwide,  have a Relative Strength Index (RSI) of 51.01.

On October 06th, 2017, Apple announced that Katherine Adams, formerly Senior Vice President and General Counsel of Honeywell, will join the Company as General Counsel and Senior Vice President of Legal and Global Security, reporting to CEO Tim Cook and serving on the executive team. The Company also announced that Bruce Sewell, who has served as its general counsel since 2009, will be retiring at the end of the year.

On October 16th, 2017, research firm Pacific Crest upgraded the Company's stock rating from 'Sector Weight' to 'Overweight', with a target price of $187 per share. Visit us today and access our complete research report on AAPL at:


Shares in George Town, the Cayman Islands-based Fabrinet ended at $37.09, up 0.46% from the last trading session. The stock recorded a trading volume of 234,000 shares. The Company's shares have gained 6.64% in the last one month. The stock is trading 2.12% below its 50-day moving average. Moreover, shares of Fabrinet, which provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of optical communication components, modules and sub-systems, industrial lasers, medical devices, and sensors, have an RSI of 49.24.

On October 23rd, 2017, Fabrinet announced that it will release its Q1 FY18 financial results for the period ended September 29th, 2017 after market close on November 06th, 2017. On that day, management will hold a conference call and webcast at 5:00 p.m. ET to review and discuss the results. The live webcast may be accessed on the Company's investor website. The complimentary report on FN can be downloaded at:

Koninklijke Philips 

Amsterdam, the Netherlands headquartered Koninklijke Philips N.V.'s stock ended yesterday's session 4.29% lower at $40.16. A total volume of 4.61 million shares was traded, which was above their three months average volume of 1.44 million shares. The Company's shares have advanced 5.38% over the previous three months and 31.37% on an YTD basis. The stock is trading 0.22% and 14.20% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Philips, which operates as a health technology company worldwide, have an RSI of 43.80.

On October 13th, 2017, Philips announced that it has received 510(k) clearance from the US FDA to market the new eL18-4 transducer with full solution for 'small parts' assessment, which is an ultrasound exam to detect abnormalities in the small organs that are close to the skin. The Philips Ultimate Small Parts Solution features four key innovations that work together to help improve patient care: the eL18-4 PureWave linear array transducer, Philips MicroFlow Imaging, Philips Elastography, and Philips Precision Biopsy. 

On October 16th, 2017, research firm Exane BNP Paribas downgraded the Company's stock rating from 'Outperform' to 'Neutral'. Register for free on and access the latest research report on PHG at:


On Tuesday, shares in Tokyo, Japan headquartered Sony Corp. recorded a trading volume of 323,317 shares. The stock finished 0.51% higher at $37.70. The Company's shares have advanced 1.97% in the last one month and 34.50% since the start of this year. The stock is trading above its 200-day moving average by 6.00%. Furthermore, shares of Sony, which designs, develops, manufactures, and sells electronic equipment, instruments, and devices for consumer, professional, and industrial markets worldwide, have an RSI of 55.20.

On October 11th, 2017, research firm Morgan Stanley downgraded the Company's stock rating from 'Overweight' to 'Equal-Weight'. Get free access to your research report on SNE at:

Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.